Citations: Fuchs,S.; Rolauffs,B.; Arndt,S.; Tibesku,C.O.; Prehm,P.. CD44H and the isoforms CD44v5 and CD44v6 in the synovial fluid of the osteoarthritic human knee joint. Osteoarthritis and Cartilage 2003;11:839-844. (Link)
Loeffler-Ragg,J.; Steurer,M.; Ulmer,H.; Skvortsov,S.; Kircher,B.; Herold,M.; Zwierzina,H.; Stauder,R.. Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromes. Leukemia 2006;20:2064-2067. (Link)
Van Hal,Nicole L.W.; van Dongen,Guus A.M.S.; Ten Brink,Corlinda B.M.; Heider,Karl Heinz; Rech-Weichselbraun,Irene; Snow,Gordon B.; Brakenhoff,Ruud H.. Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 1999;5:3534-3541. (Link)
Braumller,H.; Gansauge,S.; Ramadani,M.; Gansauge,F.. CD44v6 cell surface expression is a common feature of macrophages and macrophage-like cells - implication for a natural... FEBS Letters 2000;476:240-247. (Link)
Kanke,Minoru; Fujii,Masato; Kameyama,Kaori; Kanzaki,Jin; Tokumaru,Yutaka; Imanishi,Yorihisa; Tomita,Toshiki; Matsumura,Yasuhiro. Role of CD44 Variant Exon 6 in Invasion of Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery 2000;126:1217-1223. (Link)
Ekici,Sinan; Ayhan,Ay; Kendi,Sezer; Ozen,Haluk. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: prognostic value of CD44v6 score. The Journal of urology 2002;167:2037-2041. (Link)
Scott,David A.; Stapleton,John A.; Palmer,Richard M.; Wilson,Ron F.; Sutherland,Gay; Coward,Paula Y.; Gustavsson,Gunnar; Odell,Edward W.; Poston,Robin N.. Plasma Concentrations of Reputed Tumor-associated Soluble CD44 Isoforms (v5 and v6) in Smokers Are Dose Related and Decline on Smoking Cessation. Cancer Epidemiology Biomarkers & Prevention 2000;9:1211-1214. (Link)
Afify,Alaa; Lynne,Lin Chang; Howell,Lydia. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Diagnostic cytopathology 2007;35:105-110. (Link)
Stroomer,Joep W.G.; Roos,Jan C.; Sproll,Marlies; Quak,Jasper J.; Heider,Karl Heinz; Wilhelm,Bram J.; Castelijns,Jonas A.; Meyer,Reiner; Kwakkelstein,Marthin O.; Snow,Gordon B.; Adolf,Gunther R.; van Dongen,Guus A.M.S.. Safety and Biodistribution of 99mTechnetium-labeled Anti-CD44v6 Monoclonal Antibody BIWA 1 in Head and Neck Cancer Patients. Clinical Cancer Research 2000;6:3046-3055. (Link)
Palmer,R.M.; Stapleton,J.A.; Sutherland,G.; Coward,P.Y.; Wilson,R.F.; Scott,D.A.. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6). European Journal of Clinical Investigation 2002;32:852-857. (Link)
Franzmann,Elizabeth J.; Reategui,Erika P.; Pedroso,Felipe; Pernas,Francisco G.; Karakullukcu,Baris M.; Carraway,Kermit L.; Hamilton,Kara; Singal,Rakesh; Goodwin,W.Jarrard. Soluble CD44 Is a Potential Marker for the Early Detection of Head and Neck Cancer. Cancer Epidemiology Biomarkers & Prevention 2007;16:1348-1355. (Link)
Afify,A.M.; Craig,S.; Paulino,A.F.G.; Stern,R.. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Annals of Diagnostic Pathology 2005;9:312-318. (Link)
References: Humbria,A.; az-Gonzalez,F.; Campanero,M.R.; Arroyo,A.G.; Laffon,A.; Gonzalez-Amaro,R.; Sanchez-Madrid,F.. Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum. 1994;37:342-348. (Link)
Arch,R.; Wirth,K.; Hofmann,M.; Ponta,H.; Matzku,S.; Herrlich,P.; Zoller,M.. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992;257:682-685. (Link)
Hofmann,M.; Rudy,W.; Zoller,M.; Tolg,C.; Ponta,H.; Herrlich,P.; Gunthert,U.. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 1991;51:5292-5297. (Link)
Heider,K.H.; Dammrich,J.; Skroch-Angel,P.; Muller-Hermelink,H.K.; Vollmers,H.P.; Herrlich,P.; Ponta,H.. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res. 1993;53:4197-4203. (Link)
Stamenkovic,I.; Aruffo,A.; Amiot,M.; Seed,B.. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991;10:343-348. (Link)
Fujiwara,K.; Yoshino,T.; Miyake,K.; Ohara,N.; Akagi,T.. Expression of a lymphocyte adhesion molecule (CD44) in malignant lymphomas: relevance to primary site, histological subtype and clinical stage. Acta Med.Okayama 1993;47:215-222. (Link)
Moller,P.; Eichelmann,A.; Mechtersheimer,G.; Koretz,K.. Expression of beta 1-integrins, H-CAM (CD44) and LECAM-1 in primary gastro-intestinal B-cell lymphomas as compared to the adhesion receptor profile of the gut-associated lymphoid system, tonsil and peripheral lymph node. Int J.Cancer 1991;49:846-855. (Link)
Salmi,M.; Gron-Virta,K.; Sointu,P.; Grenman,R.; Kalimo,H.; Jalkanen,S.. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J.Cell Biol. 1993;122:431-442. (Link)
Heider,K.H.; Hofmann,M.; Hors,E.; van den,Berg F.; Ponta,H.; Herrlich,P.; Pals,S.T.. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J.Cell Biol. 1993;120:227-233. (Link)
Gunthert,U.; Hofmann,M.; Rudy,W.; Reber,S.; Zoller,M.; Haussmann,I.; Matzku,S.; Wenzel,A.; Ponta,H.; Herrlich,P.. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24. (Link)
Kuppner,M.C.; Van,Meir E.; Gauthier,T.; Hamou,M.F.; de,Tribolet N.. Differential expression of the CD44 molecule in human brain tumours. Int.J.Cancer 1992;50:572-577. (Link)
Joensuu,H.; Ristamaki,R.; Klemi,P.J.; Jalkanen,S.. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br.J.Cancer 1993;68:428-432. (Link)
Koopman,G.; Heider,K.H.; Horst,E.; Adolf,G.R.; van den,Berg F.; Ponta,H.; Herrlich,P.; Pals,S.T.. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J.Exp.Med. 1993;177:897-904. (Link)
Matsumura,Y.; Tarin,D.. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-1058. (Link)
Guo,M.M.; Hildreth,J.E.. HIV-induced loss of CD44 expression in monocytic cell lines. J.Immunol. 1993;151:2225-2236. (Link)
Omary,M.B.; Trowbridge,I.S.; Letarte,M.; Kagnoff,M.F.; Isacke,C.M.. Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 1988;27:460-464. (Link)
